The IIDR team has developed an antibiotic resistance platform (ARP) that can be used to help discover new antimicrobial drugs and preserve existing ones.
The ARP identifies antibiotic adjuvants (inhibitors of antibiotic resistance) and can be used in antibiotic dereplication. Dereplication is the process of eliminating known compounds to identify novel chemical entities. This is normally a long and laborious process that makes it difficult to identify new antibiotics. In dereplication mode, the ARP easily identifies common antibiotics.
The ARP is a powerful tool that has broad application in confronting the resistance crisis.